Skip to content

The effect of products containing artificial sweeteners on blood glucose in diabetic patients

Comparison of glycemic control in patients with type 2 diabetes on regular diabetic diet or artificial sweeteners

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
IRCT
Registry ID
IRCT2015091513612N6
Enrollment
30
Registered
2015-11-09
Start date
2014-11-22
Completion date
Unknown
Last updated
2018-02-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Diabetes. Malnutrition- related diabetes mellitus without complications

Interventions

Thirty patients with Type II Diabetes, without any nutritional intervention, were under observation for three months. Within the space of three months, after measuring the blood sugar, patients were n

Sponsors

Vice chancellor for research, Tabriz University of Medical Sciences
Lead Sponsor

Eligibility

Sex/Gender
All
Age
25 Years to 70 Years

Inclusion criteria

Inclusion criteria: Inclusion criterias: Male and Female, Age between 25-70 years old, Positive history of diabetes for at least six month, Patients who take oral remedies, Patients who did not use insulin, The patients with 25= BMI = 35 who did not have significant weight changes through last three months, Patients who did not use products containing artifitial sweeteners through last three months. Exclusion criterias: Pregnancy or lactating, Using insulin therapy, Acutr renal failure, Hepatic diseases,-weight loss through last three six months or history of regimen

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

MeasureTime frame
Fasting blood sugar. Timepoint: At baseline, after 3 months. Then after 3 months from intervention. Method of measurement: Blood sugar test.;2hpp blood sugar level. Timepoint: At baseline, after 3 months.then after 3 months from intervention. Method of measurement: Blood sugar test.;HbA1C. Timepoint: At baseline, after 3 months.then after 3 months from intervention. Method of measurement: Chromatography.

Secondary

MeasureTime frame
Body Mass Index. Timepoint: At baseline, after 3 months.then after 3 months from intervention. Method of measurement: consequence of this division: Body Weight(kg) / height^2 (m).

Countries

Iran (Islamic Republic of)

Contacts

Public ContactDr. Frazad Najafipour

Tabriz University of Medical Sciences

najafipourf@tbzmed.ac.ir+98 41 3335 7850

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026